The emerging approach of the medication represents a significant breakthrough in the care of type 2 diabetes. Unlike existing drugs, tirzepatide impacts dual pathways – the GLP-1 hormone and the GIP hormone – https://tirzepatidepeptide845843.myparisblog.com/42565089/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment